Coldstream Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Coldstream Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-16	Closed	-$20K	–	264
2016 Q1	$20K	Buy	+16	New	+$18.4K	﹤0.01%	270
2015 Q1	–	Sell	-17	Closed	-$57K	–	191
2014 Q4	$57K	Buy	17 +2	+13%	+$7.08K	0.02%	200
2014 Q3	$51K	Hold	15	–	–	0.01%	192
2014 Q2	$56K	Hold	15	–	–	0.02%	207
2014 Q1	$59K	Sell	15 -5	-25%	-$22.3K	0.02%	187
2013 Q4	$73K	Buy	20 +16	+400%	+$60.6K	0.02%	185
2013 Q3	$14K	Sell	4 -29	-88%	-$218K	﹤0.01%	179
2013 Q2	$328K	Buy	+33	New	+$366K	0.11%	112

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

Coldstream Capital Management's FRTX Position: Q2 2016 in Review

Coldstream Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2016, closing a stake of 16 shares — an estimated $20K sold.

Coldstream Capital Management first reported a position in FRTX in Q2 2013 and held it in 8 quarters. The position peaked at $328K in Q2 2013. 36 funds tracked by Wall St. Rank hold FRTX as of Q2 2016.

Coldstream Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Coldstream Capital Management sold 16 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $20K.
Coldstream Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
Coldstream Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $328K in Q2 2013.
36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Coldstream Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.